MPA, GPA and EGPA: the ANCA vasculitis family
Many people hear more than one name, or see their label change. This page explains how the three ANCA vasculitis diseases relate.
Every medical claim on this page links to its source. Last updated 15 November 2026. Educational information, not medical advice.
MPA, granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA) are grouped together as ANCA-associated vasculitis (AAV).1 They share some features and some treatments, but they are not the same disease.
- MPA often involves MPO-ANCA and commonly affects the kidneys. This site covers MPA first and most deeply.1,2
- GPA more often involves PR3-ANCA. GPA section: coming later.
- EGPA is a separate disease in the family. EGPA section: coming later.
Antibody type and clinical label can overlap. Doctors increasingly describe disease by ANCA type (MPO or PR3) as well as by name.3 Ask your team which label they use for you and why.
Many pages on this site, such as family and friends, research and the glossary, apply across the whole family.
Sources
- KDIGO: KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis [doc ref 1]
- Vasculitis Foundation: Microscopic polyangiitis (MPA) [doc ref 7]
- Rheumatology (2025): 2025 British Society for Rheumatology recommendations for ANCA-associated vasculitis [doc ref 40]
Links checked 15 November 2026. Full list: all sources.